AAAAAA

   
Results: 1-8 |
Results: 8
CENTRALIZED ECHOCARDIOGRAM QUALITY-CONTROL IN A MULTICENTER STUDY OF REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSION
Authors: GOSSE P GUEZ D GUERET P DUBOURG O BEAUCHET A DECORDOUE A BARRANDON S
Citation: P. Gosse et al., CENTRALIZED ECHOCARDIOGRAM QUALITY-CONTROL IN A MULTICENTER STUDY OF REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSION, Journal of hypertension, 16(4), 1998, pp. 531-535
NEUROPSYCHOPHYSIOLOGICAL EVALUATION OF 3 DOSES OF S-12024-2 IN MILD-TO-MODERATE ALZHEIMERS-DISEASE
Authors: DEROUESNE C RENAULT B VANDERLINDEN M LACOMBLEZ L HOMEYER P OUSS L NEUMAN E MALBEZIN M BARRANDON S GUEZ D
Citation: C. Derouesne et al., NEUROPSYCHOPHYSIOLOGICAL EVALUATION OF 3 DOSES OF S-12024-2 IN MILD-TO-MODERATE ALZHEIMERS-DISEASE, Clinical drug investigation, 14(4), 1997, pp. 301-306
REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN PATIENTS WITH ESSENTIAL-HYPERTENSION - RESULTS OF 6-MONTH TREATMENT WITH INDAPAMIDE
Authors: CURRY CL ROBINSON H BROWN R OLIVAN J SAMI M HONOS G RUDDY TD BALAZOVJECH I TOUZEK F GALINIER F MARIANI M DECORDOUE A BARRANDON S BRAULT Y GUEZ D
Citation: Cl. Curry et al., REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN PATIENTS WITH ESSENTIAL-HYPERTENSION - RESULTS OF 6-MONTH TREATMENT WITH INDAPAMIDE, American journal of hypertension, 9(8), 1996, pp. 828-832
CHARACTERIZATION OF THE APOLIPOPROTEIN-E GENOTYPES IN A EUROPEAN MULTICENTER TRIAL ON ALZHEIMERS-DISEASE WITH THE S-12024-2 (MEMORY ENHANCER)
Authors: AMOUYEL P NEUMAN E DILLEMANN L RICHARD F BARRANDON S LEPAGNOL J GUEZ D
Citation: P. Amouyel et al., CHARACTERIZATION OF THE APOLIPOPROTEIN-E GENOTYPES IN A EUROPEAN MULTICENTER TRIAL ON ALZHEIMERS-DISEASE WITH THE S-12024-2 (MEMORY ENHANCER), Neurology, 46(2), 1996, pp. 14003-14003
TREATMENT OF HYPERTENSION WITH INDAPAMIDE 1.5 MG SUSTAINED-RELEASE FORM - SYNTHESIS OF RESULTS
Authors: GUEZ D MALLION JM DEGAUTE JP MALINI PL BALDWIN R RODRIGUEZPUJOL D DECORDOUE A BARRANDON S CHASTANG C SAFAR M
Citation: D. Guez et al., TREATMENT OF HYPERTENSION WITH INDAPAMIDE 1.5 MG SUSTAINED-RELEASE FORM - SYNTHESIS OF RESULTS, Archives des maladies du coeur et des vaisseaux, 89, 1996, pp. 17-25
TROUGH PEAK RATIO (T/P) OF INDAPAMIDE 1.5 MG SUSTAINED-RELEASE FORM ASSESSED BY AMBULATORY BLOOD-PRESSURE MONITORING (ABPM)/
Authors: MALLION JM ASMAR R AMBROSIONI E MACMAHON M COUPEZ JM DECORDOUE A BARRANDON S BRAULT Y GUEZ D SAFAR M
Citation: Jm. Mallion et al., TROUGH PEAK RATIO (T/P) OF INDAPAMIDE 1.5 MG SUSTAINED-RELEASE FORM ASSESSED BY AMBULATORY BLOOD-PRESSURE MONITORING (ABPM)/, Archives des maladies du coeur et des vaisseaux, 89, 1996, pp. 27-38
THERAPEUTIC BENEFIT OF A LOW-DOSAGE OF IN DAPAMIDE - RESULT OF A DOUBLE-BLIND, PLACEBO-CONTROLLED EUROPEAN STUDY
Authors: ASMAR R GUEZ D MALBEZIN M BRAULT Y DECORDOUE A BARRANDON S BRUXELLES MC CHASTANG C
Citation: R. Asmar et al., THERAPEUTIC BENEFIT OF A LOW-DOSAGE OF IN DAPAMIDE - RESULT OF A DOUBLE-BLIND, PLACEBO-CONTROLLED EUROPEAN STUDY, Archives des maladies du coeur et des vaisseaux, 88(8), 1995, pp. 1083-1087
CLINICAL AND NEUROPHYSIOLOGICAL EVALUATION OF 3 DOSES OF S120242 (50,100, 200 MG OD) DURING REPEATED ORAL-ADMINISTRATION (7 DAYS) IN 12 OUT-PATIENTS WITH MILD-TO-MODERATE ALZHEIMERS-DISEASE
Authors: DEROUESNE C RENAULT B GUEGUEN B VANDERLINDEN M LACOMBLEZ L HOMEYER P OUSS L NEUMAN E MALBEZIN M BARRANDON S GUEZ D
Citation: C. Derouesne et al., CLINICAL AND NEUROPHYSIOLOGICAL EVALUATION OF 3 DOSES OF S120242 (50,100, 200 MG OD) DURING REPEATED ORAL-ADMINISTRATION (7 DAYS) IN 12 OUT-PATIENTS WITH MILD-TO-MODERATE ALZHEIMERS-DISEASE, Neurobiology of aging, 15, 1994, pp. 190000100-190000100
Risultati: 1-8 |